AptarGroup, Inc. (ATR)

Several events have influenced AptarGroup's stock price over the past six months. The stock has increased by approximately 7.9% since the beginning of the year, trading around $131.57 as of April 10, 2026. AptarGroup reported strong fourth-quarter 2025 results, with sales increasing 14% to $963 million and adjusted EPS of $1.25, leading to an 8.22% jump in the stock price on February 6, 2026. The Board of Directors approved a new share repurchase program of up to $600 million, boosting investor confidence. AptarGroup received an upgrade to "Overweight" from "Equal Weight" by Wells Fargo in March 2026. Management has indicated a projected decline in emergency medicine revenue, specifically a 35% decline in sales of Naloxone consumables in 2026, due to customers accumulating excess inventory. AptarGroup is well-positioned to benefit from the anticipated surge in demand for GLP-1 weight loss medications. Gael Touya will be the next Chief Executive Officer, with Stephan B. Tanda retiring by the end of the year.

AptarGroup experiences some demand seasonality, particularly within its Pharma segment, where the first quarter (Q1) is generally the lowest margin quarter seasonally. The company anticipates continued strong growth in its Pharma segment overall, excluding emergency medicine, and expects margin recovery in the second half of the year. Demand for specific products can also exhibit trends; for instance, emergency medicine sales have seen a period of destocking and are projected to decline in 2026, while demand for injectable products, including GLP-1 drugs, is experiencing robust growth. The Beauty segment has shown strengthening demand in prestige fragrance.

AptarGroup, Inc. is a global manufacturer specializing in consumer dispensing packaging and drug delivery devices, operating within the Basic Materials sector (Containers & Packaging industry) and the Medical Devices & Instruments industry. The company's product portfolio includes dispensing pumps, fine-mist pumps, lotion pumps, closures, aerosol valves, metered-dose inhaler valves, nasal spray systems, elastomer components, active packaging solutions, and digital health solutions. AptarGroup's business is segmented into Pharma, Beauty, and Closures.

AptarGroup has a significant global presence with operations in 20 countries across North America, Europe, Asia, and South America. Europe accounts for 49% of its revenue, followed by the United States at 28%, China at 5%, and other countries contributing 17%.

AptarGroup has received positive recognition for its corporate responsibility and sustainability efforts. Aptar was named one of America's Most Responsible Companies 2026 by Newsweek for the seventh consecutive year, ranking 56th out of 600 U.S. companies. The company was also recognized by Forbes as one of the World's Top Companies for Women and by TIME as one of the World's Most Sustainable Companies. Additionally, Aptar achieved an "A" score for climate change from the Climate Disclosure Project (CDP) for the fourth consecutive year in January 2026.

AptarGroup's ownership is largely held by institutional investors, who collectively hold approximately 92.30% of the company's shares. Major institutional shareholders include Vanguard Group Inc., BlackRock, Inc., State Farm Mutual Automobile Insurance Co, Morgan Stanley, State Street Corp, Victory Capital Management Inc, Mawer Investment Management Ltd., Geode Capital Management, Llc, Boston Trust Walden Corp, and Dimensional Fund Advisors Lp. Insider ownership accounts for around 0.78% of the outstanding stock.